Ondine Biomedical (LON:OBI) Stock Price Up 1.7% – Here’s What Happened

Ondine Biomedical Inc. (LON:OBI)’s share price traded up 1.7% during mid-day trading on Friday . The company traded as high as C$15.50 and last traded at C$15.25. 1,201,245 shares were traded during trading, an increase of 280% from the average session volume of 316,169 shares. The stock had previously closed at C$15.00.

Ondine Biomedical Stock Up 1.7%

The company has a current ratio of 1.36, a quick ratio of 8.26 and a debt-to-equity ratio of 25.95. The stock’s 50-day moving average is C$14.38 and its 200-day moving average is C$11.50. The company has a market cap of C$6.77 billion, a price-to-earnings ratio of -217.86 and a beta of 0.10.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.